TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Bispecific Antibodies for Cancer Market
Bispecific Antibodies for Cancer Market by Player, Region, Type, Application and Sales Channel 2024-2030

Bispecific Antibodies for Cancer Market by Player, Region, Type, Application and Sales Channel 2024-2030

  • Category:Life Sciences
  • Published on : 15 July 2024
  • Pages :91
  • Formats:
  • Report Code:SMR-7970603
OfferClick for best price

Best Price: $2600

Bispecific Antibodies for Cancer Market Size, Share 2024


Market size in 2023 US$ 1.8 billion
 Forecast Market size by 2030 US$ 17.4 billion
Growth Rate CAGR of 36.1% Number of Pages 91 Pages

The global Bispecific Antibodies for Cancer market was valued at US$ 1.8 billion in 2023 and is projected to reach US$ 17.4 billion by 2030, at a CAGR of 36.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report studies the Bispecific Antibodies for Cancer market, covering market size for segment by type (CD19/CD3, CD30/CD16A, etc.), by application (Hematological Cancers, Solid Tumors, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Amgen, Immunocore, Roche, Astella Pharma, Merus, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Bispecific Antibodies for Cancer from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Bispecific Antibodies for Cancer market.

Leading Players of Bispecific Antibodies for Cancer including:

  • Amgen

  • Immunocore

  • Roche

  • Astella Pharma

  • Merus

  • Regeneron Pharmaceuticals

...

Market split by Type:

  • CD19/CD3

  • CD30/CD16A

Market split by Application:

  • Hematological Cancers

  • Solid Tumors

  • Others

Market split by Sales Channel:

  • Direct Channel

  • Distribution Channel

Market split by Region/Country:

  • North America (United States and Canada)

  • Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)

  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)

  • South America (Brazil, Mexico, and Argentina, etc.)

  • Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Report Attributes Report Details
Report Title Bispecific Antibodies for Cancer Market by Player, Region, Type, Application and Sales Channel 2024-2030
Market size in 2023 US$ 1.8 billion
Forecast Market size by 2030 US$ 17.4 billion
Growth Rate CAGR of 36.1%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 91 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents

Chapter 1 Bispecific Antibodies for Cancer Market Overview
1.1 Bispecific Antibodies for Cancer Definition
1.2 Global Bispecific Antibodies for Cancer Market Size Status and Outlook (2018-2032)
1.3 Global Bispecific Antibodies for Cancer Market Size Comparison by Region (2018-2032)
1.4 Global Bispecific Antibodies for Cancer Market Size Comparison by Type (2018-2032)
1.5 Global Bispecific Antibodies for Cancer Market Size Comparison by Application (2018-2032)
1.6 Global Bispecific Antibodies for Cancer Market Size Comparison by Sales Channel (2018-2032)
1.7 Bispecific Antibodies for Cancer Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Bispecific Antibodies for Cancer Market
Chapter 2 Bispecific Antibodies for Cancer Market Competition by Player
2.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Player (2021-2023)
2.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Player (2021-2023)
2.3 Global Bispecific Antibodies for Cancer Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Bispecific Antibodies for Cancer Market Segment by Type
3.1 Global Bispecific Antibodies for Cancer Market by Type
3.1.1 CD19/CD3
3.1.2 CD30/CD16A
3.2 Global Bispecific Antibodies for Cancer Sales and Market Share by Type (2018-2023)
3.3 Global Bispecific Antibodies for Cancer Revenue and Market Share by Type (2018-2023)
3.4 Global Bispecific Antibodies for Cancer Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Bispecific Antibodies for Cancer Market Segment by Application
4.1 Global Bispecific Antibodies for Cancer Market by Application
4.1.1 Hematological Cancers
4.1.2 Solid Tumors
4.1.3 Others
4.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Bispecific Antibodies for Cancer Market Segment by Sales Channel
5.1 Global Bispecific Antibodies for Cancer Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Bispecific Antibodies for Cancer Market Segment by Region & Country
6.1 Global Bispecific Antibodies for Cancer Market Size and CAGR by Region (2018-2032)
6.2 Global Bispecific Antibodies for Cancer Sales and Market Share by Region (2018-2023)
6.3 Global Bispecific Antibodies for Cancer Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Bispecific Antibodies for Cancer Market Share by Type
6.4.3 North America Bispecific Antibodies for Cancer Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Bispecific Antibodies for Cancer Market Share by Type
6.5.3 Europe Bispecific Antibodies for Cancer Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Bispecific Antibodies for Cancer Market Share by Type
6.6.3 Asia-Pacific Bispecific Antibodies for Cancer Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Bispecific Antibodies for Cancer Market Share by Type
6.7.3 South America Bispecific Antibodies for Cancer Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Bispecific Antibodies for Cancer Market Share by Type
6.8.3 Middle East & Africa Bispecific Antibodies for Cancer Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Bispecific Antibodies for Cancer Players
7.1 Amgen
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Immunocore
7.3 Roche
7.4 Astella Pharma
7.5 Merus
7.6 Regeneron Pharmaceuticals
Chapter 8 Upstream and Downstream Analysis of Bispecific Antibodies for Cancer
8.1 Industrial Chain of Bispecific Antibodies for Cancer
8.2 Upstream of Bispecific Antibodies for Cancer
8.3 Downstream of Bispecific Antibodies for Cancer
Chapter 9 Development Trend of Bispecific Antibodies for Cancer (2024-2032)
9.1 Global Bispecific Antibodies for Cancer Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

LIST OF TABLES & FIGURES

List of Tables and Figures

Figure Bispecific Antibodies for Cancer Example
Figure Global Bispecific Antibodies for Cancer Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Bispecific Antibodies for Cancer Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Bispecific Antibodies for Cancer Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Bispecific Antibodies for Cancer Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Bispecific Antibodies for Cancer Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Bispecific Antibodies for Cancer Sales by Player (2021-2023)
Table Global Bispecific Antibodies for Cancer Sales Market Share by Player (2021-2023)
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Player in 2023
Table Global Bispecific Antibodies for Cancer Revenue (Million $) by Player (2021-2023)
Table Global Bispecific Antibodies for Cancer Revenue Market Share by Player (2021-2023)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Player in 2023
Table Global Bispecific Antibodies for Cancer Average Price by Player (2021-2023)
Figure Global Bispecific Antibodies for Cancer Average Price by Player in 2023
Figure Global Bispecific Antibodies for Cancer Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Bispecific Antibodies for Cancer Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of CD19/CD3
Figure Global CD19/CD3 Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of CD30/CD16A
Figure Global CD30/CD16A Revenue (Million $) and Growth Rate (2018-2023)
Table Global Bispecific Antibodies for Cancer Sales by Type (2018-2023)
Table Global Bispecific Antibodies for Cancer Sales Market Share by Type (2018-2023)
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Type in 2023
Table Global Bispecific Antibodies for Cancer Revenue (Million $) by Type (2018-2023)
Table Global Bispecific Antibodies for Cancer Revenue Market Share by Type (2018-2023)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Type in 2023
Table Global Bispecific Antibodies for Cancer Average Price by Type (2018-2023)
Figure Global Bispecific Antibodies for Cancer Average Price by Type in 2023
Table Leading Players of Bispecific Antibodies for Cancer by Type in 2023
Figure Example of Hematological Cancers
Figure Global Bispecific Antibodies for Cancer for Hematological Cancers Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Solid Tumors
Figure Global Bispecific Antibodies for Cancer for Solid Tumors Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Others
Figure Global Bispecific Antibodies for Cancer for Others Revenue (Million $) and Growth Rate (2018-2023)
Table Global Bispecific Antibodies for Cancer Sales by Application (2018-2023)
Table Global Bispecific Antibodies for Cancer Sales Market Share by Application (2018-2023)
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Application in 2023
Table Leading Consumers of Bispecific Antibodies for Cancer by Application in 2023
Figure Example of Direct Channel
Figure Global Bispecific Antibodies for Cancer for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Bispecific Antibodies for Cancer for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Bispecific Antibodies for Cancer Revenue by Sales Channel (2018-2023)
Table Global Bispecific Antibodies for Cancer Revenue Market Share by Sales Channel (2018-2023)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Bispecific Antibodies for Cancer by Sales Channel in 2023
Table Global Bispecific Antibodies for Cancer Market Size and CAGR by Region (2018-2032)
Table Global Bispecific Antibodies for Cancer Sales by Region (2018-2023)
Table Global Bispecific Antibodies for Cancer Sales Market Share by Region (2018-2023)
Figure Global Bispecific Antibodies for Cancer Sales Market Share by Region in 2023
Table Global Bispecific Antibodies for Cancer Revenue (Million $) by Region (2018-2023)
Table Global Bispecific Antibodies for Cancer Revenue Market Share by Region (2018-2023)
Figure Global Bispecific Antibodies for Cancer Revenue Market Share by Region in 2023
Table North America Bispecific Antibodies for Cancer Sales by Country (2018-2023)
Figure North America Bispecific Antibodies for Cancer Sales Market Share by Country (2018-2023)
Table North America Bispecific Antibodies for Cancer Revenue by Country (2018-2023)
Figure North America Bispecific Antibodies for Cancer Revenue Market Share by Country (2018-2023)
Figure North America Bispecific Antibodies for Cancer Market Share by Type in 2023
Figure North America Bispecific Antibodies for Cancer Market Share by Application in 2023
Figure United States Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure United States Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Canada Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Bispecific Antibodies for Cancer Sales by Country (2018-2023)
Figure Europe Bispecific Antibodies for Cancer Sales Market Share by Country (2018-2023)
Table Europe Bispecific Antibodies for Cancer Revenue by Country (2018-2023)
Figure Europe Bispecific Antibodies for Cancer Revenue Market Share by Country (2018-2023)
Figure Europe Bispecific Antibodies for Cancer Market Share by Type in 2023
Figure Europe Bispecific Antibodies for Cancer Market Share by Application in 2023
Figure Germany Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Germany Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure UK Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure France Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure France Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Italy Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Spain Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Russia Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Bispecific Antibodies for Cancer Sales by Country (2018-2023)
Figure Asia-Pacific Bispecific Antibodies for Cancer Sales Market Share by Country (2018-2023)
Table Asia-Pacific Bispecific Antibodies for Cancer Revenue by Country (2018-2023)
Figure Asia-Pacific Bispecific Antibodies for Cancer Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Bispecific Antibodies for Cancer Market Share by Type in 2023
Figure Asia-Pacific Bispecific Antibodies for Cancer Market Share by Application in 2023
Figure China Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure China Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Japan Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Korea Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure India Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure India Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Southeast Asia Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Australia Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table South America Bispecific Antibodies for Cancer Sales by Country (2018-2023)
Figure South America Bispecific Antibodies for Cancer Sales Market Share by Country (2018-2023)
Table South America Bispecific Antibodies for Cancer Revenue by Country (2018-2023)
Figure South America Bispecific Antibodies for Cancer Revenue Market Share by Country (2018-2023)
Figure South America Bispecific Antibodies for Cancer Market Share by Type in 2023
Figure South America Bispecific Antibodies for Cancer Market Share by Application in 2023
Figure Brazil Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Brazil Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Mexico Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Argentina Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Colombia Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Bispecific Antibodies for Cancer Sales by Country (2018-2023)
Figure Middle East & Africa Bispecific Antibodies for Cancer Sales Market Share by Country (2018-2023)
Table Middle East & Africa Bispecific Antibodies for Cancer Revenue by Country (2018-2023)
Figure Middle East & Africa Bispecific Antibodies for Cancer Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Bispecific Antibodies for Cancer Market Share by Type in 2023
Figure Middle East & Africa Bispecific Antibodies for Cancer Market Share by Application in 2023
Figure Turkey Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Turkey Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure UAE Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2018-2023)
Figure South Africa Bispecific Antibodies for Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of Amgen
Table Bispecific Antibodies for Cancer Introduction of Amgen
Table Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share of Amgen (2021-2023)
Table Industrial Chain of Bispecific Antibodies for Cancer
Table Leading Consumers of Bispecific Antibodies for Cancer
Figure Global Bispecific Antibodies for Cancer Sales and Growth Rate Forecast (2024-2032)
Figure Global Bispecific Antibodies for Cancer Revenue and Growth Rate Forecast (2024-2032)
Table Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Region (2024-2032)
Table Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Type (2024-2032)
Table Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Application (2024-2032)
Table Global Bispecific Antibodies for Cancer Market Size and CAGR Forecast by Sales Channel (2024-2032)

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User License
USD Enterprise License

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount